Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1119 of 5804
-
New eye drops aim to halt worsening nearsightedness in kids
Disease control Recruiting nowAxial myopia is a type of nearsightedness that happens when the eye is too long from front to back. This causes distant vision to be blurry. Axial myopia tends to start during childhood and worsens over time (as the eyes continue to grow longer). This can lead to serious eye-rela…
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a daily pill stop leukemia relapse after transplant?
Disease control Recruiting nowThe purpose of the study is to see if a study drug called asciminib is safe and okay for people to take after they've had treatment for a type of blood cancer called Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ B-ALL). We're looking at two groups of adults:…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for rare cancers: drug combo shows promise in early trial
Disease control Recruiting nowBackground: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. It can be hard to study treatments for these diseases. One combination of drugs-enfortumab vedotin (EV) and pembrolizumab-…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New study tests simple ways to prevent dangerous sodium drop after brain surgery
Prevention Recruiting nowThe investigators are conducting this study to investigate new preventive measures for patients with low sodium levels (hyponatremia), which can occur after surgery on the pituitary gland. This hyponatremia is often caused by the syndrome of inappropriate antidiuresis (SIAD). SIA…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New trial aims to find safer treatment for dangerous scar pregnancy
Disease control Not yet recruitingThe aim of the study is to compare the effectiveness and the complications of Ultrasound guided surgical evacuation versus using combined local and systemic methotrexate injection for management of caesarean scar pregnancy.
Phase: PHASE2 • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New study tests Brain-Saving drugs for stroke patients
Disease control Not yet recruitingThis study conducted a comprehensive evaluation of commonly used neuroprotective agents in acute ischemic stroke, assessing their real-world value across six dimensions: safety, efficacy, cost-effectiveness, innovativeness, appropriateness, and accessibility. Employing a prospect…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New rotor device aims to speed up pancreatitis recovery
Disease control Recruiting nowThis is a national single-blinded prospective multicenter randomized (1:1) controlled trial, with two parallel arms, using a PROBE methodology, including patients with complicated acute necrotizing pancreatitis who require DEN of WON collection after endoscopic drainage. We will …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for advanced GI cancers: first human trial launches
Disease control Recruiting nowThis study, the first clinical trial, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of DB-1324.
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New cocktail of drugs aims to tackle tough pancreatic cancer
Disease control Not yet recruitingThis study is a prospective, open-label, single-arm clinical trial evaluating the safety and efficacy of tunlametinib in combination with gemcitabine/albumin-bound paclitaxel and an EGFR monoclonal antibody as first-line therapy in treatment-naive subjects with advanced pancreati…
Phase: PHASE4 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New triple therapy aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis open-label, single-arm study is designed to evaluate the safety and preliminary efficacy of NK010 cell injection combined with a PD-1 antibody and platinum-based chemotherapy as neoadjuvant therapy in patients with resectable non-small cell lung cancer (NSCLC). The study aim…
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Robot-Assisted microsurgery: a new frontier for tissue repair and lymphedema
Disease control Recruiting nowThe objective of this clinical study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and lymphatic surgery. The primary endpoints are: Effectiveness: Clinical Success, defined as intraoperative anasto…
Phase: NA • Sponsor: MMI (Medical Microinstruments, Inc.) • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
AI art therapy aims to ease chemo anxiety in kids
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effects of an AI-assisted interactive art therapy co-creation intervention on symptom burden, state anxiety, and emotional regulation in pediatric patients receiving chemotherapy. The study will be conducted as a parallel-grou…
Phase: NA • Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New Ultrasound-Guided procedure could reduce bleeding risk in cirrhosis patients
Disease control Not yet recruitingBleeding from esophagogastric varices in patients with liver cirrhosis is often life-threatening. Thrombocytopenia caused by hypersplenism secondary to portal hypertension is an independent risk factor for such gastrointestinal bleeding. Studies have confirmed that partial spleni…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Simple DNA test could shield gout patients from deadly skin side effects
Prevention Not yet recruitingSevere cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS), are rare but life-threatening complications that can occur after starting allopurinol for gout. The…
Phase: PHASE4 • Sponsor: Haiphong University of Medicine and Pharmacy • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Designer cells aim to calm immune system after massive heart attack
Disease control Not yet recruitingTo study the safety and efficacy of fibroblast activation protein (FAP)-targeted allogeneic immunosuppressive chimeric antigen receptor-dendritic cell (CAR-DC) in the treatment of acute myocardial infarction with cardiogenic shock and provide a new method for the treatment of acu…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Jail-Based PTSD therapy could curb overdose deaths after release
Disease control ENROLLING_BY_INVITATIONOpioid overdose is the leading cause of death among people recently released from incarceration. Recent evidence also shows a rise in stimulant use among justice-involved populations, as well as growing rates of concurrent opioid and stimulant use. Yet, while there is growing res…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gallstone breakthrough: no surgery needed?
Disease control ENROLLING_BY_INVITATIONGallstones, as a common benign gallbladder disease worldwide, have a prevalence of approximately 6.1%. Although laparoscopic cholecystectomy (LC) is currently the mainstream treatment, its associated complications cannot be overlooked, including intra-abdominal bleeding, bile lea…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Smart patch listens for breathing danger in opioid patients
Diagnosis ENROLLING_BY_INVITATIONThis study is being conducted to evaluate the ability of the Respiratory Monitoring System (RMS) to detect and predict opioid induced respiratory depression (OIRD) in post-operative surgical patients managed with opioid medications. The ability of the RMS to detect OIRD will be c…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Massive study pits semaglutide against dulaglutide to protect hearts in diabetes
Disease control CompletedInvestigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a phone app curb suicidal urges? new trial aims to find out
Symptom relief Recruiting nowThis study aims to evaluate the acceptability, safety, and preliminary efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide id…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC